{"id":80597,"date":"2020-12-21T13:31:17","date_gmt":"2020-12-21T12:31:17","guid":{"rendered":"http:\/\/ibecbarcelona.eu\/?p=80597"},"modified":"2020-12-22T14:44:50","modified_gmt":"2020-12-22T13:44:50","slug":"dermoglass-fa-el-salt-a-la-industria-farmaceutica","status":"publish","type":"post","link":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/","title":{"rendered":"La tecnologia Dermoglass aconsegueix el salt a la ind\u00fastria farmac\u00e8utica"},"content":{"rendered":"
\"\"
Grupo del IBEC \u201cBiomateriales para Terapias Regenerativas\u201d<\/figcaption><\/figure>\n

La tecnologia patentada\u00a0Dermoglass\u00a0utilitza la bioenginyeria i els\u00a0nanomaterials\u00a0per solucionar un problema que afecta al voltant de 100 milions de persones al m\u00f3n i que es considera una epid\u00e8mia silenciosa en ple segle XXI: les \u00falceres cr\u00f2niques.<\/span>\u00a0<\/span><\/p>\n

La tecnologia\u00a0<\/span>Dermoglass<\/span>\u00a0ha estat recentment llicenciada per l’IBEC a l’empresa farmac\u00e8utica Laboratoris ERN, que tindr\u00e0 els drets d’explotaci\u00f3 i comercialitzaci\u00f3 a Europa d’aquesta nova tecnologia. ERN liderar\u00e0 el desenvolupament de la tecnologia fins\u00a0<\/span>a\u00a0<\/span>arribar al mercat, amb el suport de l’IBEC en les properes fases de formulaci\u00f3 i escalat, agilitant el proc\u00e9s de transfer\u00e8ncia de la tecnologia. Amb\u00a0<\/span>Dermoglass<\/span>\u00a0els laboratoris ERN obren una nova l\u00ednia de negoci que aposta per la innovaci\u00f3 i el desenvolupament de producte propi.<\/span>\u00a0<\/span><\/p>\n

El projecte s’ha pogut desenvolupar gr\u00e0cies al suport de diferents programes de valoritzaci\u00f3 i transfer\u00e8ncia de tecnologia, entre els quals destaquen els projectes finan\u00e7ats per la Fundaci\u00f3 Banc\u00e0ria La Caixa com el “CaixaImpulse\u00a0Validate” (2015) i el “CaixaImpulse\u00a0Consolidate” (2018), claus en el proc\u00e9s d’assessorament i\u00a0mentoritzaci\u00f3. A m\u00e9s, el projecte tamb\u00e9 s’ha beneficiat del programa EIT-Health\u00a0PoC\u00a0PLUS (2016) i de la plataforma de\u00a0<\/span>crowdfunding<\/span><\/i>\u00a0Goteo\u00a0(2014) en el Programa SUMA UPC.<\/span>\u00a0<\/span><\/p>\n

El problema: les \u00falceres a la pell<\/span>\u00a0<\/strong><\/h2>\n

Les \u00falceres s\u00f3n lesions a la pell que apareixen per un deficient reg sanguini en una determinada zona del cos. Aquesta defici\u00e8ncia pot tenir causes diverses, com ara per\u00edodes llargs d’immobilitzaci\u00f3 (en un llit o cadira de rodes) o a conseq\u00fc\u00e8ncia de la diabetis, en qu\u00e8 els pacients pateixen un empitjorament de la circulaci\u00f3 sangu\u00ednia. De fet, molts malalts de diabetis solen patir de l’anomenat “peu diab\u00e8tic”, que s\u00f3n ferides en els peus que sorgeixen a conseq\u00fc\u00e8ncia de la malaltia i que en un 25% dels casos condueixen a l’amputaci\u00f3.<\/span>\u00a0<\/span><\/p>\n

El problema \u00e9s que les \u00falceres s\u00f3n molt dif\u00edcils de curar<\/span>,<\/span>\u00a0ja que cicatritzen lentament de forma espont\u00e0nia (a causa d’un deficient reg sanguini), i en un 70% dels casos tornen a apar\u00e8ixer. En les persones de m\u00e9s de 65 anys les \u00falceres s\u00f3n les ferides cr\u00f2niques m\u00e9s freq\u00fcents, per\u00f2 poden afectar a persones de qualsevol edat<\/span>,<\/span>\u00a0ja que apareixen a causa de per\u00edodes llargs d’immobilitzaci\u00f3 originats per diferents causes, com poden ser una recuperaci\u00f3 postoperat\u00f2ria o una fractura \u00f2ssia. Aquestes lesions a la pell causen dolor, dificultat en la mobilitat i moltes vegades depend\u00e8ncia per a la realitzaci\u00f3 de les cures peri\u00f2diques necess\u00e0ries. En casos m\u00e9s greus les persones han d’acudir peri\u00f2dicament a<\/span>l<\/span>\u00a0centre de salut per realitzar-les, o fins i tot ser hospitalitzades en casos m\u00e9s extrems.<\/span>\u00a0<\/span><\/p>\n

La soluci\u00f3:\u00a0Dermoglass<\/span>\u00a0<\/strong><\/h2>\n

Actualment hi ha al mercat nombrosos tipus d’ap\u00f2sits per a la pell que es fan servir en les cures de les \u00falceres cr\u00f2niques, per\u00f2 aquests simplement les protegeixen i a\u00efllen de l’ambient extern. Existeixen tamb\u00e9 ter\u00e0pies basades en c\u00e8l\u00b7lules i factors de creixement, encara que resulten molt cares i tenen contraindicacions. La innovadora tecnologia\u00a0<\/span>Dermoglass<\/span>\u00a0fa un pas m\u00e9s enll\u00e0 i aconsegueix accelerar el proc\u00e9s de cicatritzaci\u00f3 de les \u00falceres amb l’aplicaci\u00f3 de\u00a0<\/span>nanomaterials<\/span>. Aix\u00f2 redueix considerablement els efectes negatius per a les persones que les pateixen, i tamb\u00e9 els costos econ\u00f2mics associats al seu tractament.<\/span><\/span>\u00a0<\/span><\/p>\n

\"\"<\/p>\n

La tecnologia\u00a0Dermoglass, basada en nanopart\u00edcules de calci, recupera el teixit danyat estimulant c\u00e8l\u00b7lules de la pell com fibroblasts i tamb\u00e9 la\u00a0vascularitzaci\u00f3, \u00e9s a dir<\/span>,<\/span>\u00a0en la formaci\u00f3 de nous vasos sanguinis per reparar el teixit afectat. Com a resultat la curaci\u00f3 es fa de forma m\u00e9s r\u00e0pida i definitiva.<\/span>\u00a0<\/span><\/p>\n

Els resultats obtinguts fins al moment en model animal s\u00f3n molt esperan\u00e7adors i mostren que amb\u00a0Dermoglass\u00a0les \u00falceres cicatritzen m\u00e9s r\u00e0pid<\/span>ament<\/span>\u00a0que amb altres ap\u00f2sits.<\/span>
\nEl producte es troba actualment en fase precl\u00ednica i d’escalat de la producci\u00f3, i s’espera que pugui arribar als pacients en pocs anys.<\/span><\/p>\n

 <\/p>\n

 <\/p>\n

Sobre l\u00b4IBEC<\/strong><\/p>\n

L’Institut de Bioenginyeria de Catalunya (IBEC) \u00e9s un centre CERCA reconegut amb el segell d’excel\u00b7l\u00e8ncia Severo Ochoa, en dues ocasions, i amb el segell TECNIO com a desenvolupador i facilitador de tecnologia a les empreses. IBEC \u00e9s membre de l’Institut de Ci\u00e8ncia i Tecnologia de Barcelona (BIST) i porta a terme recerca interdisciplin\u00e0ria d’excel\u00b7l\u00e8ncia en la frontera de l’enginyeria i les ci\u00e8ncies de la vida per tal de generar nou coneixement integrant camps com la nanomedicina, la biof\u00edsica, la biotecnologia l’enginyeria de teixits i les aplicacions de tecnologia de la informaci\u00f3 en l’\u00e0mbit de la salut. IBEC va ser creat el 2005 per la Generalitat de Catalunya, la Universitat de Barcelona (UB) i la Universitat Polit\u00e8cnica de Catalunya (UPC).<\/span><\/p>\n

Sobre ERN<\/strong><\/p>\n

LABORATORIOS ERN, S.A.\u00e9s un laboratori farmac\u00e8utic barcelon\u00e8s, fundat el 1942, que ha arribat fins al dia d\u2019avui a trav\u00e9s de sucesives fusions amb 14 petits treballadors al llarg dels seus 78 anys d\u2019hist\u00f2ria. Durant tots aquests anys, l\u2019objectiu ha estat identificar les necessitats terap\u00e8utiques del professional sanitari i posar a la seva alcance medicaments en els que es pugui confiar, tant per la seva qualitat com per les seves caracter\u00edstiques d\u2019\u00fas f\u00e0cil i bona acceptaci\u00f3 dels pacients. El 2019 es va iniciar un projecte per fomentar la col\u00b7laboraci\u00f3 amb centres d\u2019excel\u00b7l\u00e8ncia i inversi\u00f3 en Start-ups, amb l\u2019objectiu de fomentar el desenvolupament de productes innovadors per al mercat farmac\u00e8utic<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Dermoglass \u00e9s el primer projecte finan\u00e7at pel programa CaixaImpulse que es llicencia a una empresa farmac\u00e8utica, concretament a Laboratoris ERN. Es tracta d\u2019una nova tecnologia desenvolupada pel grup d\u2019investigaci\u00f3 \u201cBiomaterials per a Ter\u00e0pies Regeneratives\u201d, liderat per la Dra. Elisabeth Engel de l\u2019Institut de Bioenginyeria de Catalunya (IBEC) i la Catedr\u00e0tica de la Universitat Polit\u00e8cnica de Catalunya (UPC). <\/h3>\n","protected":false},"author":4,"featured_media":80558,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[96],"tags":[583,1348,770,1347],"post_formats":[],"class_list":["post-80597","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticies-de-recerca","tag-caixaimpulse-ca","tag-dermoglass-ca","tag-elisabeth-engel-ca","tag-ulcera"],"yoast_head":"\nLa tecnologia Dermoglass aconsegueix el salt a la ind\u00fastria farmac\u00e8utica - Institute for Bioengineering of Catalonia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La tecnologia Dermoglass aconsegueix el salt a la ind\u00fastria farmac\u00e8utica - Institute for Bioengineering of Catalonia\" \/>\n<meta property=\"og:description\" content=\"Dermoglass \u00e9s el primer projecte finan\u00e7at pel programa CaixaImpulse que es llicencia a una empresa farmac\u00e8utica, concretament a Laboratoris ERN. Es tracta d\u2019una nova tecnologia desenvolupada pel grup d\u2019investigaci\u00f3 \u201cBiomaterials per a Ter\u00e0pies Regeneratives\u201d, liderat per la Dra. Elisabeth Engel de l\u2019Institut de Bioenginyeria de Catalunya (IBEC) i la Catedr\u00e0tica de la Universitat Polit\u00e8cnica de Catalunya (UPC).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/\" \/>\n<meta property=\"og:site_name\" content=\"Institute for Bioengineering of Catalonia\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-21T12:31:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-22T13:44:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/Elisabeth-Engel-1-scaled-e1608553852803.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c0ngels L\u00f3pez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c0ngels L\u00f3pez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/\"},\"author\":{\"name\":\"\u00c0ngels L\u00f3pez\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#\\\/schema\\\/person\\\/c212c6b589546130be67986b9290e2b8\"},\"headline\":\"La tecnologia Dermoglass aconsegueix el salt a la ind\u00fastria farmac\u00e8utica\",\"datePublished\":\"2020-12-21T12:31:17+00:00\",\"dateModified\":\"2020-12-22T13:44:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/\"},\"wordCount\":954,\"publisher\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/Elisabeth-Engel-1-scaled-e1608553852803.jpg\",\"keywords\":[\"CaixaImpulse\",\"Dermoglass\",\"Elisabeth Engel\",\"\u00falcera\"],\"articleSection\":[\"Not\u00edcies de recerca\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/\",\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/\",\"name\":\"La tecnologia Dermoglass aconsegueix el salt a la ind\u00fastria farmac\u00e8utica - Institute for Bioengineering of Catalonia\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/Elisabeth-Engel-1-scaled-e1608553852803.jpg\",\"datePublished\":\"2020-12-21T12:31:17+00:00\",\"dateModified\":\"2020-12-22T13:44:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/Elisabeth-Engel-1-scaled-e1608553852803.jpg\",\"contentUrl\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/Elisabeth-Engel-1-scaled-e1608553852803.jpg\",\"width\":2560,\"height\":1707},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La tecnologia Dermoglass aconsegueix el salt a la ind\u00fastria farmac\u00e8utica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#website\",\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/\",\"name\":\"Institute for Bioengineering of Catalonia\",\"description\":\"Bioengineering Solutions for Health\",\"publisher\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ibecbarcelona.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#organization\",\"name\":\"Institute for Bioengineering of Catalonia\",\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cropped-IBEC_20ANYS_GRIS.png\",\"contentUrl\":\"https:\\\/\\\/ibecbarcelona.eu\\\/wp-content\\\/uploads\\\/2026\\\/01\\\/cropped-IBEC_20ANYS_GRIS.png\",\"width\":696,\"height\":257,\"caption\":\"Institute for Bioengineering of Catalonia\"},\"image\":{\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ibecbarcelona.eu\\\/#\\\/schema\\\/person\\\/c212c6b589546130be67986b9290e2b8\",\"name\":\"\u00c0ngels L\u00f3pez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/09ad6ba116bea0b15c5511860f83b302579fd7404c1180e9dae55c3f11d988c6?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/09ad6ba116bea0b15c5511860f83b302579fd7404c1180e9dae55c3f11d988c6?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/09ad6ba116bea0b15c5511860f83b302579fd7404c1180e9dae55c3f11d988c6?s=96&d=mm&r=g\",\"caption\":\"\u00c0ngels L\u00f3pez\"},\"url\":\"https:\\\/\\\/ibecbarcelona.eu\\\/ca\\\/author\\\/alopez\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La tecnologia Dermoglass aconsegueix el salt a la ind\u00fastria farmac\u00e8utica - Institute for Bioengineering of Catalonia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/","og_locale":"ca_ES","og_type":"article","og_title":"La tecnologia Dermoglass aconsegueix el salt a la ind\u00fastria farmac\u00e8utica - Institute for Bioengineering of Catalonia","og_description":"Dermoglass \u00e9s el primer projecte finan\u00e7at pel programa CaixaImpulse que es llicencia a una empresa farmac\u00e8utica, concretament a Laboratoris ERN. Es tracta d\u2019una nova tecnologia desenvolupada pel grup d\u2019investigaci\u00f3 \u201cBiomaterials per a Ter\u00e0pies Regeneratives\u201d, liderat per la Dra. Elisabeth Engel de l\u2019Institut de Bioenginyeria de Catalunya (IBEC) i la Catedr\u00e0tica de la Universitat Polit\u00e8cnica de Catalunya (UPC).","og_url":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/","og_site_name":"Institute for Bioengineering of Catalonia","article_published_time":"2020-12-21T12:31:17+00:00","article_modified_time":"2020-12-22T13:44:50+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/Elisabeth-Engel-1-scaled-e1608553852803.jpg","type":"image\/jpeg"}],"author":"\u00c0ngels L\u00f3pez","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"\u00c0ngels L\u00f3pez","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/#article","isPartOf":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/"},"author":{"name":"\u00c0ngels L\u00f3pez","@id":"https:\/\/ibecbarcelona.eu\/#\/schema\/person\/c212c6b589546130be67986b9290e2b8"},"headline":"La tecnologia Dermoglass aconsegueix el salt a la ind\u00fastria farmac\u00e8utica","datePublished":"2020-12-21T12:31:17+00:00","dateModified":"2020-12-22T13:44:50+00:00","mainEntityOfPage":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/"},"wordCount":954,"publisher":{"@id":"https:\/\/ibecbarcelona.eu\/#organization"},"image":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/#primaryimage"},"thumbnailUrl":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/Elisabeth-Engel-1-scaled-e1608553852803.jpg","keywords":["CaixaImpulse","Dermoglass","Elisabeth Engel","\u00falcera"],"articleSection":["Not\u00edcies de recerca"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/","url":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/","name":"La tecnologia Dermoglass aconsegueix el salt a la ind\u00fastria farmac\u00e8utica - Institute for Bioengineering of Catalonia","isPartOf":{"@id":"https:\/\/ibecbarcelona.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/#primaryimage"},"image":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/#primaryimage"},"thumbnailUrl":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/Elisabeth-Engel-1-scaled-e1608553852803.jpg","datePublished":"2020-12-21T12:31:17+00:00","dateModified":"2020-12-22T13:44:50+00:00","breadcrumb":{"@id":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/#primaryimage","url":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/Elisabeth-Engel-1-scaled-e1608553852803.jpg","contentUrl":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/Elisabeth-Engel-1-scaled-e1608553852803.jpg","width":2560,"height":1707},{"@type":"BreadcrumbList","@id":"https:\/\/ibecbarcelona.eu\/ca\/dermoglass-fa-el-salt-a-la-industria-farmaceutica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ibecbarcelona.eu\/ca\/"},{"@type":"ListItem","position":2,"name":"La tecnologia Dermoglass aconsegueix el salt a la ind\u00fastria farmac\u00e8utica"}]},{"@type":"WebSite","@id":"https:\/\/ibecbarcelona.eu\/#website","url":"https:\/\/ibecbarcelona.eu\/","name":"Institute for Bioengineering of Catalonia","description":"Bioengineering Solutions for Health","publisher":{"@id":"https:\/\/ibecbarcelona.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ibecbarcelona.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/ibecbarcelona.eu\/#organization","name":"Institute for Bioengineering of Catalonia","url":"https:\/\/ibecbarcelona.eu\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/ibecbarcelona.eu\/#\/schema\/logo\/image\/","url":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2026\/01\/cropped-IBEC_20ANYS_GRIS.png","contentUrl":"https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2026\/01\/cropped-IBEC_20ANYS_GRIS.png","width":696,"height":257,"caption":"Institute for Bioengineering of Catalonia"},"image":{"@id":"https:\/\/ibecbarcelona.eu\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ibecbarcelona.eu\/#\/schema\/person\/c212c6b589546130be67986b9290e2b8","name":"\u00c0ngels L\u00f3pez","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/secure.gravatar.com\/avatar\/09ad6ba116bea0b15c5511860f83b302579fd7404c1180e9dae55c3f11d988c6?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/09ad6ba116bea0b15c5511860f83b302579fd7404c1180e9dae55c3f11d988c6?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/09ad6ba116bea0b15c5511860f83b302579fd7404c1180e9dae55c3f11d988c6?s=96&d=mm&r=g","caption":"\u00c0ngels L\u00f3pez"},"url":"https:\/\/ibecbarcelona.eu\/ca\/author\/alopez\/"}]}},"AFP_featured_media_urls":{"full":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/Elisabeth-Engel-1-scaled-e1608553852803.jpg",2560,1707,false],"thumbnail":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/Elisabeth-Engel-1-150x150.jpg",150,150,true],"medium":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/Elisabeth-Engel-1-300x200.jpg",300,200,true],"medium_large":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/Elisabeth-Engel-1-768x512.jpg",768,512,true],"large":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/Elisabeth-Engel-1-1024x683.jpg",1024,683,true]},"AFP_attachments":{"full":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/EEngel_group2-scaled.jpg",2560,1786,false],"thumbnail":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/EEngel_group2-150x150.jpg",150,150,true],"medium":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/EEngel_group2-300x209.jpg",300,209,true],"medium_large":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/EEngel_group2-768x536.jpg",768,536,true],"large":["https:\/\/ibecbarcelona.eu\/wp-content\/uploads\/2020\/12\/EEngel_group2-1024x714.jpg",1024,714,true]},"AFP_videos":[],"AFP_video_blocks":"","AFP_category_names":["Not\u00edcies de recerca"],"_links":{"self":[{"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/posts\/80597","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/comments?post=80597"}],"version-history":[{"count":6,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/posts\/80597\/revisions"}],"predecessor-version":[{"id":80623,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/posts\/80597\/revisions\/80623"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/media\/80558"}],"wp:attachment":[{"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/media?parent=80597"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/categories?post=80597"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/tags?post=80597"},{"taxonomy":"post_format","embeddable":true,"href":"https:\/\/ibecbarcelona.eu\/ca\/wp-json\/wp\/v2\/post_formats?post=80597"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}